Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

The neuroendocrinology of chronic fatigue syndrome and fibromyalgia.

Parker AJ, Wessely S, Cleare AJ.

Psychol Med. 2001 Nov;31(8):1331-45. Review.

PMID:
11722149
2.
3.

24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.

Di Giorgio A, Hudson M, Jerjes W, Cleare AJ.

Psychosom Med. 2005 May-Jun;67(3):433-40.

PMID:
15911907
4.
5.

Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.

Gaab J, Engert V, Heitz V, Schad T, Schürmeyer TH, Ehlert U.

J Psychosom Res. 2004 Apr;56(4):419-24.

PMID:
15094026
6.
7.

Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome.

Neeck G, Crofford LJ.

Rheum Dis Clin North Am. 2000 Nov;26(4):989-1002. Review.

PMID:
11084955
8.

Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.

Scott LV, Burnett F, Medbak S, Dinan TG.

Psychol Med. 1998 Mar;28(2):285-93.

PMID:
9572086
9.

[Disorder of adrenal gland function in chronic fatigue syndrome].

Zarković M, Pavlović M, Pokrajac-Simeunović A, Cirić J, Beleslin B, Penezić Z, Ognjanović S, Savić S, Poluga J, Trbojević B, Drezgić M.

Srp Arh Celok Lek. 2003 Sep-Oct;131(9-10):370-4. Serbian.

10.

The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.

Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F.

Stress. 2007 Mar;10(1):13-25. Review.

PMID:
17454963
11.

Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome.

Crofford LJ, Young EA, Engleberg NC, Korszun A, Brucksch CB, McClure LA, Brown MB, Demitrack MA.

Brain Behav Immun. 2004 Jul;18(4):314-25.

PMID:
15157948
12.

Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome.

Jerjes WK, Cleare AJ, Wessely S, Wood PJ, Taylor NF.

J Affect Disord. 2005 Aug;87(2-3):299-304.

PMID:
15922454
13.

The 1microg short Synacthen test in chronic fatigue syndrome.

Hudson M, Cleare AJ.

Clin Endocrinol (Oxf). 1999 Nov;51(5):625-30.

PMID:
10594524
14.

The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.

Glass JM, Lyden AK, Petzke F, Stein P, Whalen G, Ambrose K, Chrousos G, Clauw DJ.

J Psychosom Res. 2004 Oct;57(4):391-8.

PMID:
15518675
15.

The HPA axis and the genesis of chronic fatigue syndrome.

Cleare AJ.

Trends Endocrinol Metab. 2004 Mar;15(2):55-9. Review.

PMID:
15036250
16.

The neuroendocrinology of chronic fatigue syndrome: focus on the hypothalamic-pituitary-adrenal axis.

Scott LV, Dinan TG.

Funct Neurol. 1999 Jan-Mar;14(1):3-11. Review. No abstract available.

PMID:
10321324
17.

Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome.

Jerjes WK, Taylor NF, Peters TJ, Wessely S, Cleare AJ.

Psychosom Med. 2006 Jul-Aug;68(4):578-82.

PMID:
16868267
18.

Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome.

Jerjes WK, Peters TJ, Taylor NF, Wood PJ, Wessely S, Cleare AJ.

J Psychosom Res. 2006 Feb;60(2):145-53.

PMID:
16439267
19.

The neuroendocrinology of chronic fatigue syndrome.

Cleare AJ.

Endocr Rev. 2003 Apr;24(2):236-52. Review.

PMID:
12700181
20.

Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia).

Young AH, Sharpe M, Clements A, Dowling B, Hawton KE, Cowen PJ.

Biol Psychiatry. 1998 Feb 1;43(3):236-7.

PMID:
9494707
Items per page

Supplemental Content

Write to the Help Desk